Generated May 26, 2026 at 10:55 AM ET
· Covers May 26 trading day
· 10 of 75 ready 8-Ks selected
· AI-assisted overview
Several high-materiality filings highlighted leadership transitions, regulatory milestones, and M&A activity. Dropbox appointed Ashraf Alkarmi as co-CEO with Drew Houston becoming Executive Chairman, while Outlook Therapeutics gained FDA appeal approval for LYTENAVA and plans a June 2026 BLA resubmission. TeraWulf acquired the 1+ GW Muskie Data Campus in Kentucky, Northern Oil & Gas entered Canada with a CA$350M Duvernay stake, and National Fuel Gas filed financials for its $2.62B CenterPoint Ohio acquisition. Cartesian Therapeutics secured up to $150M in debt financing and disclosed its CMO's resignation, and Corbus Pharmaceuticals reported positive CRB-701 clinical data with a registrational study planned for summer 2026.
leadership
neutral
materiality 0.80
May 26, 2026 13:15 UTC
Dropbox appoints Ashraf Alkarmi as co-CEO; Drew Houston to become Executive Chairman; Q2/FY26 guidance reaffirmed
- Ashraf Alkarmi, previously GM Core, appointed co-CEO effective May 26, 2026; will become sole CEO after transition; Drew Houston to become Executive Chairman.
- Alkarmi receives $825k base salary, 100% target bonus, and RSUs valued at $12.656M vesting over four years.
- Michael Torres appointed Chief Product Officer effective July 7, 2026; previously VP Product at Alphabet/Chrome and VP/GM Kindle at Amazon.
OTLK
Outlook Therapeutics, Inc.
regulatory
positive
materiality 0.85
May 26, 2026 11:15 UTC
FDA grants Outlook Therapeutics appeal; BLA resubmission planned for June 2026
- FDA concluded substantial evidence of effectiveness for LYTENAVA (bevacizumab-vikg) for nAMD after FDR appeal.
- Company will resubmit BLA as Class 1 in June 2026; PDUFA decision expected within 60 days.
- Appeal resolves December 30, 2025 Complete Response Letter; FDA directs final labeling discussions.
m_and_a
positive
materiality 0.75
May 26, 2026 12:06 UTC
TeraWulf acquires 1+ GW hyperscale AI/HPC campus in Eastern Kentucky (Muskie Data Campus)
- Acquired 285-acre Muskie Data Campus in Eastern Kentucky from Industrial Equity Partners; closed May 22, 2026.
- Site expected to support over 1 GW data center capacity; initial 500 MW in H2 2028, additional 500 MW in H2 2030.
- Kentucky Power (AEP) building 345 kV substation connected to 765 kV network; long-term power agreements executed.
MBOT
Microbot Medical Inc.
regulatory
positive
materiality 0.70
May 26, 2026 12:30 UTC
Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.
- Israeli Ministry of Health's AMAR Division grants marketing clearance for LIBERTY Endovascular Robotic System in Israel.
- First regulatory approval outside the U.S.; enables Free Sale Certificate for submissions in other jurisdictions.
- Company targets CE Mark certification by end of 2026 for EU market expansion.
RNAC
Cartesian Therapeutics, Inc.
debt
positive
materiality 0.85
May 26, 2026 11:08 UTC
Cartesian secures up to $150M debt facility; CMO resigns; Phase 3 data expected Q1 2027
- Secured up to $150M credit facility with K2 HealthVentures; initial $50M tranche funded at close on May 22, 2026.
- Term loans bear interest at 8.95% or prime+2.20% (whichever greater); matures June 1, 2030 with monthly amortization from July 2029.
- CMO Milos Miljkovic resigns effective May 31, 2026; will receive severance including six months' salary and COBRA coverage.
NOG
NORTHERN OIL & GAS, INC.
m_and_a
positive
materiality 0.85
May 26, 2026 10:39 UTC
NOG enters Canada with CA$350M Duvernay acquisition; raises FY2026 production guidance
- Acquires 25% non-operated stake in Duvernay light oil assets for CA$350M (~US$259M); CA$113M in NOG stock plus CA$237M cash.
- Assets include ~4,000 Boe/d (80% light oil), 75,000 net acres, ~500 gross locations with <$50 WTI breakevens.
- Effective date April 1, 2026; expected close late Q2 2026; long-term joint development agreement with Parallax.
CYPH
CYPHERPUNK TECHNOLOGIES INC.
regulatory
positive
materiality 0.60
May 26, 2026 12:00 UTC
Cypherpunk regains compliance with Nasdaq minimum bid price rule
- Received Nasdaq notice on May 21, 2026 confirming compliance with Listing Rule 5550(a)(2).
- Previously disclosed deficiency on March 4, 2026 due to closing bid price below $1.00 for 30 consecutive days.
- Nasdaq has closed the matter; company avoids delisting risk.
UP
Wheels Up Experience Inc.
debt
positive
materiality 0.75
May 26, 2026 10:57 UTC
Delta extends lock-up on 35.6% stake through May 2027; Wheels Up closes $68M equipment facility
- Delta extended lock-up on all its shares of Wheels Up common stock through May 22, 2027; shares represent ~35.6% of outstanding.
- Closed $68M Series B Revolving Equipment Notes Facility, net proceeds ~$64.3M.
- Total borrowing capacity under Revolving Equipment Notes Facilities increased to $400M.
m_and_a
neutral
materiality 0.75
May 26, 2026 12:56 UTC
NFG files financials for $2.62B CenterPoint Ohio acquisition; close expected Q4 2026
- Purchase price $2.62B: $1.42B cash at close + $1.2B 364-day seller promissory note.
- Transaction expected to close Q4 2026; cannot close before Oct 1, 2026 without seller consent.
- Conditions include HSR antitrust review expiration and PUCO approval.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
other_material
positive
materiality 0.85
May 26, 2026 12:56 UTC
Corbus reports CRB-701 42.9% cORR in 2L OPSCC at 3.6 mg/kg; registrational study planned summer 2026
- cORR 42.9% (9/21) in 2L OPSCC at 3.6 mg/kg; median DOR 6.3 mo, PFS 5.6 mo.
- cORR 34.4% (11/32) in 2L cervical cancer at 3.6 mg/kg; 2 complete responses, DOR 8.0 mo.
- Safety: treatment discontinuations 2.8%; no Grade 5 events; ocular AEs manageable.